CDKN1C mutations: two sides of the same coin

THOMAS EGGERMANN; GERHARD BINDER; FREDERIC BRIOUDE; EAMONN R. MAHER; PABLO LAPUNZINA; MARIA VITTORIA CUBELLIS; BERGADÁ I; DIRK PRAWITT; MATTHIAS BEGEMANN

TRENDS IN MOLECULAR MEDICINE

ELSEVIER SCI LTD

Lugar: Amsterdam; Año: 2014

1471-4914

Cyclin-dependent kinase (CDK)-inhibitor 1C (CDKN1C) negatively regulates cellular proliferation and it has been shown that loss-of-function mutations in the imprinted CDKN1C gene (11p15.5) are associated with the overgrowth disorder Beckwith?Wiedemann syndrome (BWS). With recent reports of gain-of-function mutations of the PCNA domain of CDKN1C in growth-retarded patients with IMAGe syndrome or Silver?Russell syndrome (SRS), its key role for growth has been confirmed. Thereby, the last gap in the spectrum of molecular alterations in 11p15.5 in growth-retardation and overgrowth syndromes could be closed. Recent functional studies explain the strict association of CDKN1C mutations with clinically opposite phenotypes and thereby contribute to our understanding of the function and regulation of the gene in particular and epigenetic regulation in general.